Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Aamdal

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1992
Can ondansetron hydrochloride (Zofran) enhance the nephrotoxic potential of other drugs?S Aamdal
International Journal of Cancer|November 15, 1984
Human tumor xenografts transplanted under the renal capsule of conventional mice. Growth rates and host immune responseS Aamdal, O Fodstad, A Pihl
Cancer Treatment Reviews|December 1, 1987
Some procedures to reduce cis-platinum toxicity reduce antitumour activityS Aamdal, O Fodstad, A Pihl
Annales Chirurgiae Et Gynaecologiae. Supplementum|January 1, 1985
The six-day subrenal capsule assay (SRCA) for testing the response of human tumours to anticancer agents. Validity and usefulness in cancer research and treatmentS Aamdal, O Fodstad, A Pihl
Cancer Chemotherapy and Pharmacology|January 1, 1988
Sodium thiosulfate fails to increase the therapeutic index of intravenously administered cis-diamminedichloroplatinum (II) in mice bearing murine and human tumorsS Aamdal, O Fodstad, A Pihl
Cancer Letters|June 30, 1990
Neuron specific enolase (NSE) in serum of patients with malignant melanomaE Wibe, E Paus, S Aamdal
Anticancer Research|July 1, 1985
Methodological aspects of the 6-day subrenal capsule assay for measuring the response of human tumors to anticancer agentsS Aamdal, O Fodstad, A Pihl
British Journal of Cancer|April 1, 1987
Mitozolomide (NSC 353451), a new active drug in the treatment of malignant melanoma. Phase II trial in patients with advanced diseaseS Gundersen, S Aamdal, O Fodstad
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Capillary protein leak syndrome appears to explain fluid retention in cancer patients who receive docetaxel treatmentK A Semb, S Aamdal, P Oian
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Sequential administration of dacarbazine and fotemustine in patients with disseminated malignant melanoma--an effective combination with unexpected toxicityS Aamdal, B Gerard, T Bohman, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1992
Can ondansetron hydrochloride (Zofran) enhance the nephrotoxic potential of other drugs?S Aamdal
International Journal of Cancer|November 15, 1984
Human tumor xenografts transplanted under the renal capsule of conventional mice. Growth rates and host immune responseS Aamdal, O Fodstad, A Pihl
Cancer Treatment Reviews|December 1, 1987
Some procedures to reduce cis-platinum toxicity reduce antitumour activityS Aamdal, O Fodstad, A Pihl
Annales Chirurgiae Et Gynaecologiae. Supplementum|January 1, 1985
The six-day subrenal capsule assay (SRCA) for testing the response of human tumours to anticancer agents. Validity and usefulness in cancer research and treatmentS Aamdal, O Fodstad, A Pihl
Cancer Chemotherapy and Pharmacology|January 1, 1988
Sodium thiosulfate fails to increase the therapeutic index of intravenously administered cis-diamminedichloroplatinum (II) in mice bearing murine and human tumorsS Aamdal, O Fodstad, A Pihl
Cancer Letters|June 30, 1990
Neuron specific enolase (NSE) in serum of patients with malignant melanomaE Wibe, E Paus, S Aamdal
Anticancer Research|July 1, 1985
Methodological aspects of the 6-day subrenal capsule assay for measuring the response of human tumors to anticancer agentsS Aamdal, O Fodstad, A Pihl
British Journal of Cancer|April 1, 1987
Mitozolomide (NSC 353451), a new active drug in the treatment of malignant melanoma. Phase II trial in patients with advanced diseaseS Gundersen, S Aamdal, O Fodstad
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Capillary protein leak syndrome appears to explain fluid retention in cancer patients who receive docetaxel treatmentK A Semb, S Aamdal, P Oian
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Sequential administration of dacarbazine and fotemustine in patients with disseminated malignant melanoma--an effective combination with unexpected toxicityS Aamdal, B Gerard, T Bohman, et al.
Pageof 7